Italo Biaggioni1, David A Calhoun2. 1. From the Division of Clinical Pharmacology, Departments of Medicine and Pharmacology, Vanderbilt University School of Medicine, Nashville, TN (I.B.) and the Vascular Biology and Hypertension Program, Division of Cardiovascular Medicine, Department of Medicine, The University of Alabama at Birmingham (D.A.C.). Italo.biaggioni@vanderbilt.edu. 2. From the Division of Clinical Pharmacology, Departments of Medicine and Pharmacology, Vanderbilt University School of Medicine, Nashville, TN (I.B.) and the Vascular Biology and Hypertension Program, Division of Cardiovascular Medicine, Department of Medicine, The University of Alabama at Birmingham (D.A.C.).
Authors: Daniel J Gottlieb; Naresh M Punjabi; Reena Mehra; Sanjay R Patel; Stuart F Quan; Denise C Babineau; Russell P Tracy; Michael Rueschman; Roger S Blumenthal; Eldrin F Lewis; Deepak L Bhatt; Susan Redline Journal: N Engl J Med Date: 2014-06-12 Impact factor: 91.245